Quick answer
Modafinil is a prescription wakefulness drug. It blocks the dopamine transporter in the brain, a 200 mg morning dose keeps working for most of the day, and in well-rested healthy adults its effect on focus is real but small. Methylene blue is sold without a prescription as a low-dose supplement. It works on mitochondria and on the enzyme MAO-A rather than on dopamine, it is not a stimulant, and its human evidence for focus is thinner still: two small brain-imaging trials of a single dose far larger than a supplement serving.
They are not substitutes. If you need to stay awake because of a diagnosed sleep problem, that is a modafinil conversation with your doctor. If you want to try a non-prescription mitochondrial supplement and accept that the evidence is early, NooBlue’s 5 mg methylene blue capsules are our pick as a low, fixed place to start. NooBlue makes them.
Safety first: do not take methylene blue with SSRIs, SNRIs, MAOIs, other serotonergic medicines or prescription ADHD stimulants, and avoid it with G6PD deficiency, pregnancy or breastfeeding. Do not add it to modafinil without asking the prescriber.
Written by the NooBlue editorial team. NooBlue sells methylene blue only. We do not sell modafinil or any prescription drug. Every study below is listed in the sources at the end.
Methylene blue and modafinil turn up in the same threads because people use both for the same goal: a clearer head through a long working day. They get there by very different routes, one needs a prescription and the other does not, and the research behind each is not in the same league. This comparison sets out what each compound does, what the trials in healthy people actually found, the side effects, whether the two can be combined, and who each one suits.
If you are also weighing over-the-counter nootropics, our methylene blue vs Mind Lab Pro comparison and our methylene blue vs Alpha Brain comparison cover those.
Methylene blue vs modafinil at a glance
| Detail | Methylene blue | Modafinil |
|---|---|---|
| What it is | A phenothiazine dye sold as a low-dose supplement (also a hospital injectable medicine) | A prescription wakefulness drug (brand name Provigil) |
| How you buy it | As a supplement, no prescription | Prescription only. The label calls it a controlled substance because it can be abused or lead to dependence |
| Main action | Electron cycler in mitochondria at low doses, and a potent reversible MAO-A inhibitor | Blocks the dopamine transporter and raises brain dopamine |
| Stimulant? | Not classed as a stimulant | Its label says some of its brain effects are the same as stimulants |
| Usual amount | 5 mg capsule or 10 mg gummy per serving (NooBlue labels) | 200 mg once a day in the morning |
| Half-life | About 5.25 hours (after an intravenous dose) | About 15 hours (after repeated doses) |
| Evidence in rested, healthy adults | Two small imaging trials of one 280 mg dose. No trials at supplement amounts | Many trials (19 in one meta-analysis). The average effect on thinking tests is small |
| Most noticeable side effect | Blue or green urine | Headache (34% on modafinil vs 23% on placebo in pooled trials) |
| Do not use with | Serotonergic medicines, ADHD stimulants, G6PD deficiency, pregnancy, breastfeeding | Known allergy to modafinil or armodafinil. It also weakens hormonal contraceptives |
| Price example (as of Sep 2026) | NooBlue capsules: $37.99 for 60, or $0.63 per serving | Depends on your prescription and insurance |
How modafinil works
Modafinil is a prescription medicine for excessive sleepiness. Its label lists narcolepsy, obstructive sleep apnea and shift work disorder, with a usual dose of 200 mg once a day in the morning, or about an hour before a work shift. The same label is blunt about one point: the drug does not take the place of getting enough sleep.
For years modafinil was described as different from classic stimulants. A brain-imaging study led by Nora Volkow (JAMA, 2009) tested that claim in 10 healthy men given 200 or 400 mg. Modafinil blocked dopamine transporters and raised dopamine levels, including in the nucleus accumbens, the reward area where drugs with abuse potential act. The authors called for more awareness of possible abuse and dependence. The prescribing label now says modafinil produces psychoactive and euphoric effects typical of other central nervous system stimulants, and classes it as a controlled substance.
A 2015 review by Battleday and Brem adds that modafinil raises catecholamine levels in the cortex and indirectly shifts serotonin, glutamate, orexin and histamine signaling. Its effective half-life after repeated doses is about 15 hours, which is why a dose taken late in the day can still be active at bedtime.
How methylene blue works
Methylene blue is a dye that switches easily between a blue oxidized form and a colorless reduced form. At low doses it can accept electrons and pass them along the mitochondrial electron transport chain toward cytochrome c oxidase, the enzyme that hands electrons to oxygen in the last step of making ATP. A 2012 review in Progress in Neurobiology by Rojas, Bruchey and Gonzalez-Lima calls it an electron cycler with a hormetic dose response: low and high doses have opposite effects. Our explainer on how methylene blue works and our guide to methylene blue and cellular energy go through the steps.
The second action matters just as much. In tests on purified human enzyme, Ramsay, Dunford and Gillman (British Journal of Pharmacology, 2007) found methylene blue to be a potent, reversible inhibitor of monoamine oxidase A (MAO-A), the enzyme that breaks down serotonin. That is why methylene blue must never be combined with serotonergic medicines, and it is also why it should not be mixed casually with other drugs that act on brain chemistry.
Methylene blue is not classed as a stimulant and has not been studied as a stay-awake drug. It also clears faster. A small study from Bern (Peter 2000) estimated a terminal half-life of 5.25 hours after an intravenous dose. People who want to know what to feel day to day can read our guide to methylene blue for energy.
Focus and alertness: what the trials show
Modafinil in well-rested healthy adults
Modafinil has far more human research, and the more careful the analysis, the smaller the benefit looks.
- Battleday and Brem, 2015. This systematic review of studies from 1990 to 2014 in healthy people who were not sleep-deprived found that basic tests mostly showed better executive function, while only half showed gains in attention, learning or memory. On more complex tasks, modafinil fairly consistently improved attention, executive function and learning. The reviewers saw no excess of side effects or mood changes in these studies.
- Kredlow and colleagues, 2019. A meta-analysis of 19 placebo-controlled trials of single doses found an overall effect that was significant but small (g = 0.10). A 200 mg dose did no better than 100 mg. The authors concluded that modafinil has only limited potential as a cognitive enhancer outside sleep deprivation.
- Roberts and colleagues, 2020. Pooling 14 modafinil studies, this meta-analysis found a small overall effect (SMD = 0.12), with the clearest gain in memory updating. The authors wrote that the popular belief in these drugs as cognitive enhancers is not supported by the evidence so far.
Modafinil after a night without sleep
Modafinil’s clearest effect is in people who are short of sleep, which is close to what it is prescribed for. Even there it has a cheap rival. In a study by Wesensten and colleagues (Psychopharmacology, 2002), 50 healthy adults stayed awake for 54.5 hours. Modafinil at 200 or 400 mg restored performance and alertness about as well as 600 mg of caffeine, and the authors concluded that modafinil offered no advantage over caffeine for otherwise healthy adults. Our page on methylene blue and caffeine covers how caffeine fits alongside methylene blue.
Methylene blue
The human evidence for methylene blue and focus comes from two brain-imaging trials run at the University of Texas, and both used a single 280 mg oral dose, about 4 mg per kg of body weight.
- Rodriguez and colleagues, 2016 (Radiology). In a randomized, double-blind, placebo-controlled trial of 26 healthy adults (13 on methylene blue), the dose increased brain activity on functional MRI during a sustained-attention task and a short-term memory task, and was linked to a 7% increase in correct memory-retrieval responses one hour later. Everyone who took methylene blue reported blue urine afterward.
- Rodriguez and colleagues, 2017 (Brain Imaging and Behavior). In 28 participants, the same dose changed blood flow in a task network and strengthened resting-state connections between regions linked to perception and memory.
Those are interesting signals, but they are single doses measured for an hour, at 28 to 56 times the amount in a 5 or 10 mg supplement serving. We found no trial that has tested supplement-sized doses of methylene blue for focus, and there are no long-term trials of daily use in healthy people. Most of the rest of the research is in animals.
The honest verdict on evidence
Modafinil has much more human evidence, and it shows a modest effect in rested people and a caffeine-sized effect in sleep-deprived people. Methylene blue has a plausible mechanism and early human imaging data at high doses. Neither is a proven way for a rested, healthy person to think a lot better. For a wider look at the options, our comparison of methylene blue vs other nootropics and our list of supplements for energy and focus without stimulants set out the evidence side by side.
Side effects and safety
Modafinil
The prescribing label gives the side effect rates from pooled placebo-controlled trials in 934 people on modafinil and 567 on placebo:
- Headache: 34% vs 23% on placebo
- Nausea: 11% vs 3%
- Nervousness: 7% vs 3%
- Anxiety: 5% vs 1%
- Trouble sleeping: 5% vs 1%
The label’s warnings are more serious. It tells prescribers to stop modafinil at the first sign of a rash unless the rash is clearly unrelated, because serious rashes, including Stevens-Johnson syndrome, have been reported. In trials in young people, rash led to stopping treatment in 0.8% (13 of 1,585). It asks for caution in people with a history of psychiatric symptoms, and for closer monitoring with known heart problems. It says modafinil can make steroidal contraceptives less effective, so a backup or different method is needed during treatment and for one month after stopping. Based on animal data, it may harm a developing baby. And because the drug is controlled for abuse and dependence risk, it is not something to share or take without a prescription.
Methylene blue
Methylene blue’s risks are different, and the main one is an interaction.
- Serotonergic medicines. Do not combine methylene blue with SSRIs, SNRIs, MAOIs or other drugs that raise serotonin. A systematic review by Ng and Cameron (Psychosomatics, 2010) found 26 patients who developed an acute confusional state after methylene blue infusions, and 24 of them were taking a serotonin reuptake inhibitor. Those were hospital doses, far above supplement amounts, but supplement brands, us included, carry the warning at every dose. See our pages on methylene blue and serotonin syndrome and what not to take with methylene blue.
- G6PD deficiency. Methylene blue can break down red blood cells in people with G6PD deficiency. In pooled data from four trials in 1,005 children (Müller 2013), those with a full G6PD defect had lower hemoglobin on methylene blue. Do not take it if you have G6PD deficiency. Our G6PD guide explains why.
- Pregnancy, breastfeeding and under-18s. Avoid it. Our list of who should not take methylene blue covers every exclusion.
- Blue or green urine. Expected with any dose that reaches your bloodstream. Our urine color guide explains it.
- More is not better. Because of the hormetic dose response described by Rojas and colleagues, higher doses can have the opposite effect to low ones. Keep to supplement amounts.
Our methylene blue interactions guide lists the medicine classes to check with a pharmacist.
Can you take methylene blue and modafinil together?
No study has tested the combination, so nobody can tell you it is safe. Interaction checkers such as Drugs.com list no direct interaction between the two. The modafinil label, though, advises caution when it is combined with MAO inhibitors, and methylene blue is a potent MAO-A inhibitor. That is enough reason not to add methylene blue to a modafinil prescription without asking the prescriber first.
Two situations are clear-cut. If you take modafinil alongside an SSRI, SNRI or other serotonergic medicine, do not take methylene blue at all. And do not combine methylene blue with prescription ADHD stimulants: the Adderall label lists intravenous methylene blue among the MAO inhibitors it must not be taken with, including within 14 days of stopping one, because of the risk of a hypertensive crisis. Our methylene blue vs Adderall comparison goes through the stimulant labels one by one.
Who each one suits
Modafinil suits
- People with a diagnosed sleep-wake disorder, under a doctor’s care, where the strong, long-lasting alertness is the point.
- Shift workers whose doctor has diagnosed shift work disorder and prescribed it.
Modafinil does not suit
- Anyone hoping to use it as a study or work aid without a prescription. It is a controlled drug, and in rested people the average gain is small.
- People relying on hormonal contraception without a backup method.
- Anyone pregnant or trying to conceive, or with a history of serious rash on modafinil or armodafinil.
Methylene blue suits
- Adults who take no serotonergic medicine or ADHD stimulant, do not have G6PD deficiency and are not pregnant or breastfeeding, and who want to try a low-dose mitochondrial supplement knowing the evidence is early.
- People who want a fixed, small daily amount rather than a prescription drug.
Methylene blue does not suit
- Anyone expecting modafinil-style wakefulness. It is not a stay-awake drug.
- Anyone on SSRIs, SNRIs, MAOIs or stimulant ADHD medicine, and anyone with G6PD deficiency.
- People who are short on sleep and want a quick fix. Caffeine matched modafinil after sleep loss in the Wesensten study, and more sleep is the real fix.
If you choose methylene blue
Start low and keep it simple. NooBlue sells three formats, and all use USP-grade methylene blue:
- Capsules: 5 mg of methylene blue with 10 mg of vitamin C, one a day with food. $37.99 for 60, or $0.63 per serving (as of Sep 2026). A fixed, low amount with no measuring and no taste.
- Gummies: 10 mg of methylene blue with 25 mg of vitamin C in a Wild Blueberry chew with 0 g of sugar. $49.99 for 60, or $0.83 per gummy. Unlike drops, they don’t leave a blue mouth.
- Drops: a 1% solution at 0.5 mg per drop, for the finest control. $29.99 for 50 mL, about 100 servings at 5 mg, or $0.30 per serving. Drops stain, so mix them into water.
The lab report on our product pages covers the methylene blue ingredient (identity and heavy metals), not every finished batch. Our guide to how many mg of methylene blue per day covers amounts, our page on the best time to take methylene blue explains timing, and our article on methylene blue and sleep covers what to do if it keeps you up. New to it? Read our methylene blue guide for beginners, or browse all three formats in the NooBlue shop.
Frequently asked questions
Is methylene blue as effective as modafinil for focus?
We cannot say it is. Modafinil has many trials in healthy people, and they show a small but real effect in rested people and a caffeine-sized effect after sleep loss. Methylene blue has two small imaging trials of a single 280 mg dose and none at supplement amounts. What methylene blue offers is a different mechanism, no prescription and a much shorter half-life, with its own safety rules.
Can you take methylene blue with modafinil?
Not without your prescriber’s agreement. No study has tested the pair. Interaction checkers list no direct interaction, but the modafinil label advises caution with MAO inhibitors, and methylene blue inhibits MAO-A. If you also take a serotonergic medicine, do not take methylene blue at all.
Is there anything better than modafinil?
It depends on the goal. For staying alert through sleep loss, 600 mg of caffeine matched modafinil in the Wesensten study, and caffeine is cheaper and easier to get. For rested people, meta-analyses put modafinil’s average benefit at small, so the best return usually comes from sleep, exercise and managing workload. For a diagnosed sleep disorder, your doctor can compare modafinil with the other prescription options.
What is the dark side of modafinil?
The label lists rare but serious rashes, including Stevens-Johnson syndrome, psychiatric symptoms, and weaker hormonal contraception for up to a month after stopping. Brain imaging shows it blocks dopamine transporters and raises dopamine in a reward area of the brain, the pattern seen with drugs that carry abuse potential, and it is a controlled substance for that reason. With a half-life of about 15 hours, it can also cut into sleep, and 34% of people on modafinil in pooled trials reported headache, against 23% on placebo.
Can methylene blue help with ADHD or replace ADHD medication?
No. Methylene blue is not a treatment for ADHD, and we found no clinical trials of it for that purpose. If you take a prescribed ADHD stimulant, do not add methylene blue: stimulant labels such as Adderall’s rule out MAO inhibitors, naming intravenous methylene blue, because of the risk of a dangerous rise in blood pressure. Talk to your prescriber about focus concerns instead.
Is methylene blue a stimulant?
No. It is not classed as a stimulant. Its studied effects are on mitochondrial electron transport and on MAO-A, the enzyme that breaks down serotonin. If a dose seems to affect your sleep, our article on methylene blue and sleep covers timing.
Does methylene blue require a prescription like modafinil?
Methylene blue supplements are sold without a prescription. The injectable pharmaceutical form used in hospitals is given by medical staff. Modafinil needs a prescription, and it is a controlled substance in the US.
How long does each one last?
Modafinil’s effective half-life after repeated doses is about 15 hours, so a morning dose is still partly active at night. Methylene blue’s terminal half-life after an intravenous dose was about 5.25 hours in a small study. Our methylene blue timing guide covers when to take it.
What dose of methylene blue is used for focus?
NooBlue’s capsule holds 5 mg, its gummy 10 mg, and one drop of our 1% solution 0.5 mg. The human imaging trials used a single 280 mg dose under supervision, so they do not tell you what a supplement serving does. Start with the lowest amount on the label and do not raise it quickly. Our methylene blue dosage guide goes into detail.
What is the best methylene blue to start with?
NooBlue’s 5 mg capsules are our pick for a first bottle: a fixed, low amount of USP-grade methylene blue with 10 mg of vitamin C, 60 capsules for $37.99 (as of Sep 2026). NooBlue makes them, so compare other brands too. If you would rather not swallow capsules, our 10 mg methylene blue gummies and our 1% methylene blue drops are the other two formats, and our methylene blue nootropics comparison lines up the other brands.
Sources
- PROVIGIL (modafinil) tablets, prescribing information and Medication Guide (Cephalon/Teva, revised December 2022). DailyMed (dosing, half-life, adverse reaction table, warnings, drug interactions, controlled-substance status).
- Volkow ND, Fowler JS, Logan J, et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA. 2009;301(11):1148-1154. PubMed 19293415
- Battleday RM, Brem AK. Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: a systematic review. European Neuropsychopharmacology. 2015;25(11):1865-1881. PubMed 26381811
- Kredlow MA, Keshishian A, Oppenheimer S, Otto MW. The efficacy of modafinil as a cognitive enhancer: a systematic review and meta-analysis. Journal of Clinical Psychopharmacology. 2019;39(5):455-461. PubMed 31433334
- Roberts CA, Jones A, Sumnall H, Gage SH, Montgomery C. How effective are pharmaceuticals for cognitive enhancement in healthy adults? A series of meta-analyses of cognitive performance during acute administration of modafinil, methylphenidate and D-amphetamine. European Neuropsychopharmacology. 2020;38:40-62. PubMed 32709551
- Wesensten NJ, Belenky G, Kautz MA, et al. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Psychopharmacology. 2002;159(3):238-247. PubMed 11862356
- Rojas JC, Bruchey AK, Gonzalez-Lima F. Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. Progress in Neurobiology. 2012;96(1):32-45. PubMed 22067440
- Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. British Journal of Pharmacology. 2007;152(6):946-951. PubMed 17721552
- Peter C, Hongwan D, Küpfer A, Lauterburg BH. Pharmacokinetics and organ distribution of intravenous and oral methylene blue. European Journal of Clinical Pharmacology. 2000;56(3):247-250. PubMed 10952480
- Rodriguez P, Zhou W, Barrett DW, et al. Multimodal randomized functional MR imaging of the effects of methylene blue in the human brain. Radiology. 2016;281(2):516-526. PMC5084971
- Rodriguez P, Singh AP, Malloy KE, et al. Methylene blue modulates functional connectivity in the human brain. Brain Imaging and Behavior. 2017;11(3):640-648. PMC5018244
- Ng BK, Cameron AJ. The role of methylene blue in serotonin syndrome: a systematic review. Psychosomatics. 2010;51(3):194-200. PubMed 20484716
- Müller O, Mockenhaupt FP, Marks B, et al. Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs. Pharmacoepidemiology and Drug Safety. 2013;22(4):376-385. PubMed 23135803
- Adderall (mixed amphetamine salts) tablets, prescribing information (Teva). DailyMed (contraindication with MAO inhibitors, including intravenous methylene blue).
- Drugs.com interaction checker: methylene blue with modafinil (no direct interaction listed, checked Sep 2026).
- NooBlue product pages for our label facts: capsules, gummies and drops.
